The 5-HT3receptor as a therapeutic target
- 20 March 2007
- journal article
- review article
- Published by Taylor & Francis in Emerging Therapeutic Targets
- Vol. 11 (4) , 527-540
- https://doi.org/10.1517/14728222.11.4.527
Abstract
The 5-HT3 receptor is a neurotransmitter-gated ion channel. It is a member of the Cys-loop family of receptors, which also includes nicotinic acetylcholine, glycine and GABAA receptors. Each member...Keywords
This publication has 142 references indexed in Scilit:
- Molecular Determinants of Picrotoxin Inhibition of 5-Hydroxytryptamine Type 3 ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative studyBJOG: An International Journal of Obstetrics and Gynaecology, 2004
- Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channelNature, 2004
- Analgesic effects of 5‐HT3receptor antagonistsScandinavian Journal of Rheumatology, 2004
- Reassessing the Benefits and Risks of AlosetronDrug Safety, 2004
- Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patientsAlimentary Pharmacology & Therapeutics, 1999
- The Non-Antiemetic Uses of Serotonin 5-HT3 Receptor AntagonistsDrugs, 1997
- Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetronPain, 1995
- Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annulated indole derivatives. 1Journal of Medicinal Chemistry, 1993
- Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1990